A Déjà Vu Moment for Women’s Health Research

In this column for Nature, Alina Salganicoff reviews efforts to improve women’s health research during previous U.S. administrations that fell short of their promise and highlights the recommendations of a congressionally mandated committee aimed at improving women’s health research at the National Institutes of Health.

Read More

Looser Health IT Certification Requirements Shift Oversight to Health Systems

The U.S. Department of Health and Human Services (HHS) is rolling back several health IT certification requirements that could reduce certification costs for technology developers. But they may leave hospitals and health systems holding more responsibility for evaluating the safety and performance of the AI tools they purchase. The post Looser Health IT Certification Requirements…

Read More

Building AI In-House at Europe’s Largest Hospital

Most hospitals buy their AI. Charité – Universitätsmedizin Berlin, Europe’s largest academic medical center and ranked eighth in the world by Newsweek, is developing its own. Charité has consolidated its scattered AI projects into a single Institute for Artificial Intelligence in Medicine and switched on Clé, an in-house platform that runs across research, teaching, patient…

Read More

Inovio’s DNA-Based Immunotherapy Lands Speedy FDA Nod for Rare Type of Tumor

Inovio’s Voceryq will compete with a Precigen product that last year became the first FDA-approved drug for recurrent respiratory papillomatosis, or RRP. While the two immunotherapies carry the same $460,000 list price, Inovio executives claim their product has another competitive advantage. The post Inovio’s DNA-Based Immunotherapy Lands Speedy FDA Nod for Rare Type of Tumor…

Read More